Brown Advisory’s Integra LifeSciences IART Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-10,212
| Closed | -$445K | – | 1267 |
|
|
2023
Q4 | $445K | Hold |
10,212
| – | – | ﹤0.01% | 965 |
|
|
2023
Q3 | $390K | Hold |
10,212
| – | – | ﹤0.01% | 969 |
|
|
2023
Q2 | $420K | Hold |
10,212
| – | – | ﹤0.01% | 948 |
|
|
2023
Q1 | $586K | Hold |
10,212
| – | – | ﹤0.01% | 878 |
|
|
2022
Q4 | $573K | Hold |
10,212
| – | – | ﹤0.01% | 875 |
|
|
2022
Q3 | $432K | Hold |
10,212
| – | – | ﹤0.01% | 893 |
|
|
2022
Q2 | $551K | Sell |
10,212
-31
| -0.3% | -$1.67K | ﹤0.01% | 828 |
|
|
2022
Q1 | $658K | Buy |
10,243
+2,579
| +34% | +$166K | ﹤0.01% | 800 |
|
|
2021
Q4 | $513K | Buy |
7,664
+39
| +0.5% | +$2.61K | ﹤0.01% | 870 |
|
|
2021
Q3 | $522K | Sell |
7,625
-2,587
| -25% | -$177K | ﹤0.01% | 820 |
|
|
2021
Q2 | $697K | Sell |
10,212
-3,600
| -26% | -$246K | ﹤0.01% | 782 |
|
|
2021
Q1 | $954K | Sell |
13,812
-5,998
| -30% | -$414K | ﹤0.01% | 715 |
|
|
2020
Q4 | $1.29M | Sell |
19,810
-453,954
| -96% | -$29.5M | ﹤0.01% | 609 |
|
|
2020
Q3 | $22.4M | Buy |
473,764
+16,903
| +4% | +$798K | 0.05% | 224 |
|
|
2020
Q2 | $21.5M | Sell |
456,861
-312,835
| -41% | -$14.7M | 0.05% | 219 |
|
|
2020
Q1 | $34.4M | Sell |
769,696
-958,020
| -55% | -$42.8M | 0.11% | 149 |
|
|
2019
Q4 | $101M | Buy |
1,727,716
+47,778
| +3% | +$2.78M | 0.26% | 83 |
|
|
2019
Q3 | $101M | Buy |
1,679,938
+232,543
| +16% | +$14M | 0.28% | 69 |
|
|
2019
Q2 | $80.8M | Buy |
1,447,395
+147,687
| +11% | +$8.25M | 0.23% | 82 |
|
|
2019
Q1 | $72.4M | Buy |
1,299,708
+287,435
| +28% | +$16M | 0.21% | 91 |
|
|
2018
Q4 | $45.7M | Buy |
+1,012,273
| New | +$45.7M | 0.15% | 131 |
|